CompletedPhase 2NCT06111872
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
Studying Choledochal cyst
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National University of Malaysia
- Principal Investigator
- Azlanudin AzmanUniversiti Kebangsaan Malaysia Medical Centre
- Intervention
- Ketamine(drug)
- Enrollment
- 90 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2024
Study locations (1)
- Hospital Canselor Tuanku Muhriz UKM, Cheras, Kuala Lumpur, Malaysia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06111872 on ClinicalTrials.govOther trials for Choledochal cyst
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07036848Efficacy and Safety of Surgical Treatment for Type IVa CBDBeijing Tsinghua Chang Gung Hospital
- RECRUITINGNCT06881004Biliary Dilatation National Special Disease Cohort in ChinaBeijing Tsinghua Chang Gung Hospital
- ENROLLING BY INVITATIONNCT05404503Analysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western CenterMaría Teresa Moreno Asencio